Skip to main content
Top
Published in: BMC Cancer 1/2024

Open Access 01-12-2024 | Metastasis | Research

Establishment and external validation of prognosis prediction nomogram for patients with distant metastatic intrahepatic cholangiocarcinoma: based on a large population

Authors: Chen Yuan, Shubing Zou, Kai Wang, Zhigang Hu

Published in: BMC Cancer | Issue 1/2024

Login to get access

Abstract

Background

Most patients with intrahepatic cholangiocarcinoma (ICC) have developed distant metastasis at the time of diagnosis, while there is rear related nomogram to predict the prognosis.

Methods

Clinical data of patients pathologically diagnosed of ICC with distant metastasis were retrospectively collected from the Surveillance, Epidemiology, and End Results (SEER) database during 2005 to 2019. Finally, patients diagnosed as ICC in the Second Affiliated Hospital of Nanchang University from 2014 to 2019 were collected for external verification. All data were divided into training cohort and validation cohort in a ratio of 7:3. The nomogram was established based on independent prognostic factors using Cox univariate and multivariate analyses. The area under the receiver operating characteristic (ROC) curves (AUC), the calibration curve and the decision curve analysis (DCA) were used to determine the prediction accuracy of the nomogram.

Results

This study finally included 572 ICC with distant metastasis patients, another 32 patients collected by the author’s hospital were used as external verification. Results showed that age, surgery, radiotherapy and chemotherapy were independent prognostic factors, and nomogram was established. The AUC of predicting 3, 6, 9-month overall survival were 0.866, 0.841 and 0.786. The ROC curves and calibration curves showed that the nomogram had good predictive accuracy, and DCA showed that the nomogram had good clinical applicability.

Conclusions

The nomogram has good accuracy in predicting prognosis of DM-ICC patients, which would be of good significance to improve the prognosis of these patients.
Literature
1.
go back to reference Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268–89.CrossRefPubMed Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268–89.CrossRefPubMed
2.
go back to reference oh Y, Hatano T, Nishio E. Significant improvement in outcomes of patients with intrahepatic cholangiocarcinoma after surgery. World J Surg. 2016;40:2229–36.CrossRef oh Y, Hatano T, Nishio E. Significant improvement in outcomes of patients with intrahepatic cholangiocarcinoma after surgery. World J Surg. 2016;40:2229–36.CrossRef
3.
go back to reference Núñez E, Steyerberg EW, Núñez J. Regression modeling strategies. Rev Esp Cardiol. 2011;64:501–7.CrossRefPubMed Núñez E, Steyerberg EW, Núñez J. Regression modeling strategies. Rev Esp Cardiol. 2011;64:501–7.CrossRefPubMed
4.
go back to reference Zhang H, Y ang T, Wu M, Shen F. Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management. Cancer Lett. 2016;379:198–205.CrossRefPubMed Zhang H, Y ang T, Wu M, Shen F. Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management. Cancer Lett. 2016;379:198–205.CrossRefPubMed
5.
go back to reference Yuan C, Hu Z, Wang K, Zou S. Development and Validation a Nomogram for Predicting overall survival in patients with Intrahepatic Cholangiocarcinoma. Front Surg. 2021;8:659422.CrossRefPubMedPubMedCentral Yuan C, Hu Z, Wang K, Zou S. Development and Validation a Nomogram for Predicting overall survival in patients with Intrahepatic Cholangiocarcinoma. Front Surg. 2021;8:659422.CrossRefPubMedPubMedCentral
7.
go back to reference Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33:1353–7.CrossRefPubMed Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33:1353–7.CrossRefPubMed
9.
go back to reference Uenishi T, Hamba H, Takemura S, et al. Outcomes of hepatic resection for hepatolithiasis. Am J Surg. 2009;198:199–202.CrossRefPubMed Uenishi T, Hamba H, Takemura S, et al. Outcomes of hepatic resection for hepatolithiasis. Am J Surg. 2009;198:199–202.CrossRefPubMed
10.
go back to reference Kim HJ, Kim JS, Suh SJ, et al. Cholangiocarcinoma risk as long-term outcome after hepatic resection in the hepatolithiasis patients. World J Surg. 2015;39:1537–42.CrossRefPubMed Kim HJ, Kim JS, Suh SJ, et al. Cholangiocarcinoma risk as long-term outcome after hepatic resection in the hepatolithiasis patients. World J Surg. 2015;39:1537–42.CrossRefPubMed
11.
go back to reference Shen X, Zhao H, Jin X, Chen J, Y u Z, Ramen K, Zheng X, Wu X, Shan Y, Bai J, Zhang Q, Zeng Q. Development and validation of a machine learning-based nomogram for prediction of intrahepatic cholangiocarcinoma in patients with intrahepatic lithiasis. HepatoBiliary Surg Nutr. 2021;10(6):749–65.CrossRefPubMedPubMedCentral Shen X, Zhao H, Jin X, Chen J, Y u Z, Ramen K, Zheng X, Wu X, Shan Y, Bai J, Zhang Q, Zeng Q. Development and validation of a machine learning-based nomogram for prediction of intrahepatic cholangiocarcinoma in patients with intrahepatic lithiasis. HepatoBiliary Surg Nutr. 2021;10(6):749–65.CrossRefPubMedPubMedCentral
12.
go back to reference Paik KY, Jung JC, Heo JS, Choi SH, Choi DW, Kim YI. What prognostic factors are important for resected intrahepatic cholangiocarcinoma? J Gastroenterol Hepatol. 2008;23:766–70.CrossRefPubMed Paik KY, Jung JC, Heo JS, Choi SH, Choi DW, Kim YI. What prognostic factors are important for resected intrahepatic cholangiocarcinoma? J Gastroenterol Hepatol. 2008;23:766–70.CrossRefPubMed
13.
go back to reference He C, Zhang Y, Cai Z, Duan F, Lin X, Li S. Nomogram to predict cancer-specific survival in patients with pancreatic acinar cell carcinoma: a competing risk analysis. J Cancer. 2018;9:4117–27.CrossRefPubMedPubMedCentral He C, Zhang Y, Cai Z, Duan F, Lin X, Li S. Nomogram to predict cancer-specific survival in patients with pancreatic acinar cell carcinoma: a competing risk analysis. J Cancer. 2018;9:4117–27.CrossRefPubMedPubMedCentral
14.
go back to reference Vickers AJ, Cronin AM, Elkin EB, Gonen M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inf Decis Mak. 2008;8:53.CrossRef Vickers AJ, Cronin AM, Elkin EB, Gonen M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inf Decis Mak. 2008;8:53.CrossRef
15.
go back to reference Dong F, Shen Y, Gao F, Shi X, Xu T, Wang X, et al. Nomograms to predict individual prognosis of patients with primary small cell carcinoma of the bladder. J Cancer. 2018;9:1152–64.CrossRefPubMedPubMedCentral Dong F, Shen Y, Gao F, Shi X, Xu T, Wang X, et al. Nomograms to predict individual prognosis of patients with primary small cell carcinoma of the bladder. J Cancer. 2018;9:1152–64.CrossRefPubMedPubMedCentral
16.
go back to reference Yuan C, Tao Q, Wang J, Wang K, Zou S, Hu Z. Nomogram based on log odds of positive Lymph nodes Predicting Cancer-specific survival in patients with T3 and T4 Gallbladder Cancer after Radical Resection. Front Surg. 2021;8:675661.CrossRefPubMedPubMedCentral Yuan C, Tao Q, Wang J, Wang K, Zou S, Hu Z. Nomogram based on log odds of positive Lymph nodes Predicting Cancer-specific survival in patients with T3 and T4 Gallbladder Cancer after Radical Resection. Front Surg. 2021;8:675661.CrossRefPubMedPubMedCentral
17.
go back to reference Hijazi Z, Oldgren J, Lindbäck J, et al. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study. Lancet. 2016;387:2302–11.CrossRefPubMed Hijazi Z, Oldgren J, Lindbäck J, et al. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study. Lancet. 2016;387:2302–11.CrossRefPubMed
18.
go back to reference Wang Y, Li J, Xia Y, Gong R, Wang K, Yan Z, Wan X, Liu G, Wu D, Shi L, Lau W, Wu M, Shen F. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol. 2013;31(9):1188–95.CrossRefPubMed Wang Y, Li J, Xia Y, Gong R, Wang K, Yan Z, Wan X, Liu G, Wu D, Shi L, Lau W, Wu M, Shen F. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol. 2013;31(9):1188–95.CrossRefPubMed
19.
go back to reference Cai Y, Zhang B, Li J, Li H, Liu H, Xie K, Du C, Wu H. A Novel Nomogram based on hepatic and coagulation function for evaluating outcomes of Intrahepatic Cholangiocarcinoma after curative hepatectomy: a Multi-center Study of 653 patients. Front Oncol. 2021;11:711061.CrossRefPubMedPubMedCentral Cai Y, Zhang B, Li J, Li H, Liu H, Xie K, Du C, Wu H. A Novel Nomogram based on hepatic and coagulation function for evaluating outcomes of Intrahepatic Cholangiocarcinoma after curative hepatectomy: a Multi-center Study of 653 patients. Front Oncol. 2021;11:711061.CrossRefPubMedPubMedCentral
20.
go back to reference Shen H, Zhang S, Xia Y, Chen C, Huo L, Gan L, Li J, Wang K, Pawlik TM, Lau WY, Wu M, Shen F. A Nomogram in Predicting risks of Intrahepatic Cholangiocarcinoma after partial hepatectomy for Hepatolithiasis. J Gastrointest Surg. 2021;25(9):2258–67.CrossRefPubMed Shen H, Zhang S, Xia Y, Chen C, Huo L, Gan L, Li J, Wang K, Pawlik TM, Lau WY, Wu M, Shen F. A Nomogram in Predicting risks of Intrahepatic Cholangiocarcinoma after partial hepatectomy for Hepatolithiasis. J Gastrointest Surg. 2021;25(9):2258–67.CrossRefPubMed
21.
go back to reference Wu X-X, Chen R-P, Chen R-C, Gong H-P, Wang B-F, Li Y-L, et al. Nomogram predicting cancer-specific mortality in patients with esophageal adenocarcinoma: a competing risk analysis. J Thorac Dis. 2019;11:2990–3003.CrossRefPubMedPubMedCentral Wu X-X, Chen R-P, Chen R-C, Gong H-P, Wang B-F, Li Y-L, et al. Nomogram predicting cancer-specific mortality in patients with esophageal adenocarcinoma: a competing risk analysis. J Thorac Dis. 2019;11:2990–3003.CrossRefPubMedPubMedCentral
22.
go back to reference Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol. 2011;185:869–75.CrossRefPubMedPubMedCentral Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol. 2011;185:869–75.CrossRefPubMedPubMedCentral
23.
go back to reference Zhou R, Lu D, Li W, Tan W, Zhu S, Chen X, et al. Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis. HPB (Oxford). 2019;21:784–92.CrossRefPubMed Zhou R, Lu D, Li W, Tan W, Zhu S, Chen X, et al. Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis. HPB (Oxford). 2019;21:784–92.CrossRefPubMed
24.
go back to reference He C, Cai Z, Zhang Y, Lin X. Prognostic model to predict cancer-specific survival for patients with gallbladder carcinoma after surgery: a population-based analysis. Front Oncol. 2019;9:1329.CrossRefPubMedPubMedCentral He C, Cai Z, Zhang Y, Lin X. Prognostic model to predict cancer-specific survival for patients with gallbladder carcinoma after surgery: a population-based analysis. Front Oncol. 2019;9:1329.CrossRefPubMedPubMedCentral
25.
go back to reference Li P, Song L. Prognostic evaluation for patients over 45 years old with gallbladder adenocarcinoma resection: a SEER-based nomogram analysis. Biomed Res Int. (2020) 2020:6370946. Li P, Song L. Prognostic evaluation for patients over 45 years old with gallbladder adenocarcinoma resection: a SEER-based nomogram analysis. Biomed Res Int. (2020) 2020:6370946.
26.
go back to reference Squires MH, Cloyd JM, Dillhoff M, Schmidt C, Pawlik TM. Challenges of surgical management of intrahepatic cholangiocarcinoma. Expert Rev Gastroenterol Hepatol. 2018;12:671–81.CrossRefPubMed Squires MH, Cloyd JM, Dillhoff M, Schmidt C, Pawlik TM. Challenges of surgical management of intrahepatic cholangiocarcinoma. Expert Rev Gastroenterol Hepatol. 2018;12:671–81.CrossRefPubMed
27.
go back to reference Ruzzenente A, Conci S, Pedrazzani ValdegamberiA, Guglielmi C. Role of surgery in the treatment of intrahepatic cholangiocarcinoma. Eur Rev Med Pharmacol Sci. 2015;19:2892–900.PubMed Ruzzenente A, Conci S, Pedrazzani ValdegamberiA, Guglielmi C. Role of surgery in the treatment of intrahepatic cholangiocarcinoma. Eur Rev Med Pharmacol Sci. 2015;19:2892–900.PubMed
28.
go back to reference Poultsides GA, Zhu AX, Choti MA, Pawlik TM. Intrahepatic cholangiocarcinoma. Surg Clin North Am. 2010;90:817–37.CrossRefPubMed Poultsides GA, Zhu AX, Choti MA, Pawlik TM. Intrahepatic cholangiocarcinoma. Surg Clin North Am. 2010;90:817–37.CrossRefPubMed
29.
go back to reference Hahn F, Müller L, Mähringer-Kunz A, Tanyildizi Y, Dos Santos DP, Düber C, Galle PR, Weinmann A, Kloeckner R. Distant metastases in patients with Intrahepatic Cholangiocarcinoma: does Location Matter? A retrospective analysis of 370 patients. J Oncol. 2020;2020:7195373.CrossRefPubMedPubMedCentral Hahn F, Müller L, Mähringer-Kunz A, Tanyildizi Y, Dos Santos DP, Düber C, Galle PR, Weinmann A, Kloeckner R. Distant metastases in patients with Intrahepatic Cholangiocarcinoma: does Location Matter? A retrospective analysis of 370 patients. J Oncol. 2020;2020:7195373.CrossRefPubMedPubMedCentral
30.
go back to reference Huitzil-Melendez FD, Capanu M, O’Reilly EM, Duffy A, Gansukh B, Saltz LL, et al. Advanced hepatocellular carcinoma: which staging systems best predict prognosis? J Clin Oncol. 2010;28:2889–95.CrossRefPubMedPubMedCentral Huitzil-Melendez FD, Capanu M, O’Reilly EM, Duffy A, Gansukh B, Saltz LL, et al. Advanced hepatocellular carcinoma: which staging systems best predict prognosis? J Clin Oncol. 2010;28:2889–95.CrossRefPubMedPubMedCentral
32.
go back to reference Talluri R, Shete S. Using the weighted area under the net benefit curve for decision curve analysis. BMC Med Inf Decis Mak. 2016;16:94.CrossRef Talluri R, Shete S. Using the weighted area under the net benefit curve for decision curve analysis. BMC Med Inf Decis Mak. 2016;16:94.CrossRef
33.
go back to reference Rousson V, Zumbrunn T. Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies. BMC Med Inf Decis Mak. 2011;11:45.CrossRef Rousson V, Zumbrunn T. Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies. BMC Med Inf Decis Mak. 2011;11:45.CrossRef
Metadata
Title
Establishment and external validation of prognosis prediction nomogram for patients with distant metastatic intrahepatic cholangiocarcinoma: based on a large population
Authors
Chen Yuan
Shubing Zou
Kai Wang
Zhigang Hu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-024-11976-6

Other articles of this Issue 1/2024

BMC Cancer 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine